Shukra Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 01/09/2022, to consider and approve draft of Director's Report and Secretarial Audit Report for the year ended March 31, 2022; to fix day, date, time and venue for Annual General meeting; to decide on the dates for closure of the Register of Members and Share Transfer Register for the purpose of Annual Book Closure; to consider and approve draft of notice for Annual General Meeting; to appoint Scrutinizer for the process of Remote E-voting as well as voting at the AGM; to appoint internal auditor of the company for Financial Year 2022-23; and any other business with the permission of chair.
The above information is a part of company’s filings submitted to BSE.
